Culture media to develop vaccines and biotherapeutics against COVID-19

With many around the world affected by the impacts of COVID-19, it is imperative that pharmaceutical companies create vaccines to help save lives. The Vero cell line, derived from African green monkey kidney, has been widely used for viral vaccine production. The Vero cell line is also used for amplification of several SARS-CoV variants. To avoid any challenges during downstream processing of recombinant protein or vaccine productions, media formulations without fetal bovine serum (FBS) are essential. ProVero^TM1 Serum-free Medium is a non-animal origin, protein-free medium designed to support the growth of MDCK and Vero cells. The absence of proteins in the medium lowers the lot to lot variability while being optimized for fast cell proliferation. Whether growing vaccines with VERO cells, insect cells, or HEK293 cells, Lonza has several serum-free media options for reducing production variables.

Learn more about Lonza's media for vaccine production.

Learn more about vaccine production to help accelerate companies' efforts to save patients’ lives.

Pharmaceutical companies and research laboratories are investigating protein based cures to fight the COVID-19 virus. This can be a monoclonal antibody, a bi-specific antibody or a protein. They can be produced in cell lines such as CHO, BHK, HEK293, NSO and Hybridoma. We can support these initiatives with our serum-free protein production media. We can support you from research to GMP manufacturing with our liquid and powder media. If required, custom formats can be produced.

Learn more about Lonza's media for protein production.

Learn more about protein and hybridoma production to help accelerate companies' efforts to cure patients.